Related Experiment Video
Updated: Apr 18, 2026

Author Spotlight: Understanding Age-Related Macular Degeneration Pathophysiology with QAF Workflow
Published on: May 26, 2023
Nutritional supplements in age-related macular degeneration
Doreen Schmidl1, Gerhard Garhöfer, Leopold Schmetterer
1Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
Abstract:
Age-related macular degeneration (AMD) is the most frequent cause of blindness in the Western World. While with new therapies that are directed towards vascular endothelial growth factor (VEGF), a potentially efficient treatment option for the wet form of the disease has been introduced, a therapeutic regimen for dry AMD is still lacking. There is evidence from several studies that oral intake of supplements is beneficial in preventing progression of the disease. Several formulations of micronutrients are currently available. The present review focuses on the role of supplements in the treatment and prevention of AMD and sums up the current knowledge about the most frequently used micronutrients. In addition, regulatory issues are discussed, and future directions for the role of supplementation in AMD are highlighted.
Related Concept Videos
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
Pharmacodynamics in Geriatric Patients: Effects of Age
Diabetic Retinopathy
iPS Cell Differentiation
Vitamins
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

